Search for: "Barr Pharmaceuticals Inc"
Results 61 - 80
of 162
Sorted by Relevance
|
Sort by Date
8 Sep 2010, 3:21 pm
Barr Labs., Inc. [read post]
13 May 2010, 4:58 pm
Barr Laboratories, Inc. [read post]
29 Jun 2010, 6:01 pm
Mylan Pharmaceuticals Inc. et al. [read post]
30 Jun 2010, 5:52 am
Mylan Pharmaceuticals Inc. et al. [read post]
25 Oct 2008, 12:03 am
Sandoz, Inc (Law360) (Hal Wegner) (Patently-O) (Patent Prospector) (PLI) Cipro (Ciprofloxacin) - US: CAFC finds no antitrust liability for Hatch-Waxman reverse payment settlements: In Re Ciproflaxacin Hydrochloride Antitrust Litigation (IP Law Observer) Lescol (Fluvastatin) - US: Mylan confirms first-to-file patent challenge to Lescol by Novartis (SmartBrief) Levaquin (Levofloxacin) - UK: Levofloxacin SPC valid: Generics (UK) Ltd v Daiichi Pharmaceutical Co Ltd & Anor… [read post]
5 May 2009, 5:57 am
Barr Pharmaceuticals, 07-395, U.S. [read post]
18 Mar 2010, 2:30 am
Mylan Pharmaceuticals, Inc. et al. [read post]
24 Mar 2010, 4:45 am
Synthon Pharmaceuticals, Inc. [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
24 Dec 2008, 3:00 pm
Apotex, Inc (Managing Intellectual Property) [read post]
26 Apr 2011, 11:15 pm
Barr Pharmaceutical manufactured Claravis, which contains the same active agent as Accutane (isotretinoin). [read post]
24 Nov 2010, 12:37 am
General Global pharmaceutical linkage regulations: A consortium framework (IP Osgoode) Pfizer rolling out generics to grab off-patent market (GenericsWeb) Australia: Too little too late: CSL Limited v Novo Nordisk Pharmaceuticals Pty Ltd (No 2) and the judicial discretion to amend a patent (IP Whiteboard) Brazil: You lost your chance! [read post]
8 Jun 2010, 2:29 pm
Barr Labs., Inc. [read post]
25 Nov 2009, 9:07 am
Yaz and Yasmin are manufactured by Bayer Healthcare Pharmaceuticals, Inc. [read post]
3 Mar 2010, 12:49 pm
Bayer, makers of the popular, but problematic birth control drug Yaz and Yasmin wrote that there were, about 1,100 lawsuits pending in the United States served on Bayer on behalf of persons alleged to have suffered personal injuries, some of them fatal, from the use of Bayer’s oral contraceptive products Yasmin®, yaz® and / or Ocella, a generic version of Yasmin® distributed by Barr Laboratories, Inc. in the u.s. market. [read post]
14 Jul 2020, 10:24 am
Barr Laboratories, Inc., 40 F.3d 1223 (Fed. [read post]
27 Nov 2013, 4:30 am
Therefore, the date plaintiffs “ingested Pliva’s product predates the merger of Barr, Pliva, Inc’s subsidiary and Teva. [read post]
27 Aug 2012, 9:31 am
Barr Labs., Inc., 251 F.3d 955, 968 (Fed. [read post]
27 Aug 2012, 9:31 am
Barr Labs., Inc., 251 F.3d 955, 968 (Fed. [read post]
